DK3065749T3 - Farmaceutisk sammensætnng omfattende saccharomyces boulardii til reduktion af fedtmasse - Google Patents

Farmaceutisk sammensætnng omfattende saccharomyces boulardii til reduktion af fedtmasse Download PDF

Info

Publication number
DK3065749T3
DK3065749T3 DK14808522.8T DK14808522T DK3065749T3 DK 3065749 T3 DK3065749 T3 DK 3065749T3 DK 14808522 T DK14808522 T DK 14808522T DK 3065749 T3 DK3065749 T3 DK 3065749T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
composition including
fat mass
mass reduction
saccharomyces boulardii
Prior art date
Application number
DK14808522.8T
Other languages
English (en)
Inventor
Patrice D Cani
Amandine Everard
Lucie Geurts
Marc Verleye
Guern Marie-Emmanuelle Le
Emilie Fargier
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Application granted granted Critical
Publication of DK3065749T3 publication Critical patent/DK3065749T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK14808522.8T 2013-11-08 2014-11-07 Farmaceutisk sammensætnng omfattende saccharomyces boulardii til reduktion af fedtmasse DK3065749T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20130306537 EP2870969A1 (fr) 2013-11-08 2013-11-08 Composition pharmaceutique pour la réduction de la masse adipeuse
PCT/EP2014/074109 WO2015067788A1 (fr) 2013-11-08 2014-11-07 Composition pharmaceutique pour la reduction de la masse adipeuse

Publications (1)

Publication Number Publication Date
DK3065749T3 true DK3065749T3 (da) 2020-09-28

Family

ID=49622767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14808522.8T DK3065749T3 (da) 2013-11-08 2014-11-07 Farmaceutisk sammensætnng omfattende saccharomyces boulardii til reduktion af fedtmasse

Country Status (9)

Country Link
US (1) US20160287649A1 (da)
EP (2) EP2870969A1 (da)
CA (1) CA2929197C (da)
DK (1) DK3065749T3 (da)
ES (1) ES2821386T3 (da)
LT (1) LT3065749T (da)
PL (1) PL3065749T3 (da)
PT (1) PT3065749T (da)
WO (1) WO2015067788A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3685681B1 (en) * 2019-01-23 2024-07-31 Lesaffre et Compagnie A yeast product, and a composition comprising it, for use as a prebiotic agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0956867A1 (de) * 1998-05-12 1999-11-17 Franz-Peter Dr. Liebel Verwendung von Flavonoidglykosiden, Gerbstoffen und Mikroorganismen zur Therapie und Prophylaxe des Diabetes mellitus
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
EP2419115B1 (fr) * 2009-04-15 2014-12-31 Actigenomics S.A. Composition destinee a la regulation du metabolisme des lipides
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
CA3092314A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Also Published As

Publication number Publication date
ES2821386T3 (es) 2021-04-26
PL3065749T3 (pl) 2021-01-25
EP2870969A1 (fr) 2015-05-13
CA2929197C (fr) 2022-07-12
US20160287649A1 (en) 2016-10-06
LT3065749T (lt) 2020-12-10
EP3065749A1 (fr) 2016-09-14
CA2929197A1 (fr) 2015-05-14
WO2015067788A1 (fr) 2015-05-14
EP3065749B1 (fr) 2020-06-24
PT3065749T (pt) 2020-09-28

Similar Documents

Publication Publication Date Title
FR21C1059I2 (fr) Compositions pharmaceutiques
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3003075T3 (da) Kit til inhalering af fordampede substanser
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
PL2943181T3 (pl) Kompozycje farmaceutyczne
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
ZA201408333B (en) Pharmaceutical compositions
DK2838545T3 (da) Sammensætning der omfatter urter
DK3027750T3 (da) Biokatalytisk sammensætning
EP2990038A4 (en) SOLID PHARMACEUTICAL COMPOSITION
BR112015010372A2 (pt) composições antiperspirantes sólidas em bastão
DK2956010T4 (da) Fedtsammensætning
SG11201601477VA (en) Pharmaceutical composition
DK2945899T3 (da) Overlastsikring til container-krananlæg
DK3003401T3 (da) Farmaceutisk præparat
DK3200598T3 (da) Sammensætninger til at reducere aciditet
HRP20171888T1 (hr) Farmaceutski pripravci
HK1220143A1 (zh) 藥物組合物
DK3065749T3 (da) Farmaceutisk sammensætnng omfattende saccharomyces boulardii til reduktion af fedtmasse
GB201304699D0 (en) Pharmaceutical compositions
DK3082855T3 (da) Sammensætning
TH1501002579B (th) วิธีการจ่ายผงวัสดุในการเคลือบทับ
GB201321497D0 (en) Pharmaceutical compositions